Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mirjam C. Gerber
Observed names:
M C Gerber,
Mirjam Gerber
Observed institutions:
Pfizer (United States),
Harrington Cancer Center,
The Ohio State University
OpenAlex ID:
A5033747732
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
1997
·
S M Swain
, F S Whaley
, et al.
·
Journal of Clinical Oncology
·
662
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
1997
·
S M Swain
, F S Whaley
, et al.
·
Journal of Clinical Oncology
·
269
Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs
2007
·
Gregory A. Otterson
, Miguel A. Villalona-Calero
, et al.
·
Clinical Cancer Research
·
130
Drug interactions with cimetidine: An update
1985
·
Mirjam C. Gerber
, Gopi A. Tejwani
, et al.
·
Pharmacology & Therapeutics
·
53
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
1996
·
Stephen A. Feig
, Matthew M. Ames
, et al.
·
Medical and Pediatric Oncology
·
36
Phase II Study of Intravenous Idarubicin in Unfavorable Non-Hodgkin's Lymphoma
1993
·
Delvyn C. Case
, Mirjam C. Gerber
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
9
Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.
1992
·
D C Case
, M C Gerber
, et al.
·
PubMed
·
9
Show more works
View as search
Works count:
7
Citation count:
1,168
H-index:
7
I10-index:
5
Year
Topic
Type
